Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Clinical trial NCT02728258 · COMPLETED

Trial details

NCT number: NCT02728258
Sponsor: NRG Oncology
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Endometrioid Adenocarcinoma Endometrial Mixed Cell Adenocarcinoma Endometrial Serous Adenocarcinoma Endometrial Undifferentiated Carcinoma Metastatic Endometrioid Adenocarcinoma Recurrent Uterine Corpus Cancer

Start date: 2016-09-16
Primary completion: 2018-08-18
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.